Navigation Links
Neuralstem ALS trial in multiple presentations at upcoming American Academy of Neurology meeting
Date:4/6/2011

ROCKVILLE, April 6, Maryland, 2011 Neuralstem, Inc. (NYSE Amex: CUR) announced that the Phase I safety trial of its human spinal cord stem cells (HSSCs) in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) is the subject of three presentations at the American Academy of Neurology (AAN) Annual Meeting, April 9-16th, in Honolulu, HI (http://www.aan.com/go/am11). Chief among these will be a presentation by Eva Feldman, M.D., Ph.D., who is an unpaid consultant to Neuralstem and the Principal Investigator in the ongoing ALS trial, entitled: "A Phase I, Open-Label, First-In-Human Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis," at 2:00 PM, April 11th, (http://www.abstracts2view.com/aan/view.php?nu=AAN11L_P01.287). Dr. Feldman, who is also Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System, will present interim safety data on the first nine patients in the study.

Dr. Feldman's presentation was also chosen to be highlighted in the "Scientific Program Highlights Plenary Session" mediated by the Chair of the AAN Science Committee at 5:15 on April 15th. Inclusion in this session is by invitation only; Dr. Feldman's presentation was considered by the committee to be in the top 5% of submitted abstracts, which numbered in the thousands.

"We are thrilled to receive this level of interest and review from our peers at this prestigious neurology conference," Dr. Feldman commented. "As a doctor who sees ALS patients in the clinic, I am particularly eager to share this promising research with the scientists and clinicians of the American Academy of Neurology who continue to battle this difficult disease for their patients."

In addition
'/>"/>

Contact: Deanne Eagle
deanneeagle@gmail.com
917-837-5866
Neuralstem, Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Neuralstem files FDA application for first drug therapy
2. Neuralstem updates ALS clinical trial progress
3. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
4. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
5. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
6. Neuralstem updates clinical trial progress
7. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
8. Diabetes treatment may also provide protection against endometrial cancer
9. For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial
10. Clinical trial seeks to determine whether platelet-rich plasma can ease the pain of osteoarthritis
11. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2015)... April 26, 2015 Compare-autoinsurance.org has released a ... insurance quotes . , The easiest way to find low ... have access to the best offers online, in a simple ... different providers for information about auto insurance prices. All the ... web page. , It is now possible to compare ...
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... April 26, 2015 Forbes Living ... city is one which is synonymous with clean beaches, sparkling ... and education are major economic influencers in the city on ... dynamic talk show are pleased to announce the show will ... 26 at 3:00 PM PDT. Tune in to find out ...
(Date:4/25/2015)... Portland, ME (PRWEB) April 26, 2015 ... a Canadian based integrative healthcare event. The Integrative ... taking place October 23-24, 2015 at the Sheraton ... Healthcare Symposium Canada is one of the most ... a clinically relevant, evidenced-based CME program. The event ...
(Date:4/25/2015)... April 25, 2015 In the United ... and above needed treatment for an illicit drug ... Substance Abuse and Mental Health Services Administration’s Survey on ... these alarming numbers are harrowing stories of men and ... abuse . David H. Kerr , founder and ...
Breaking Medicine News(10 mins):Health News:Finding Low Cost Auto Insurance - An Online Guide Provides Tips 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Integrative Healthcare Event launching in Canada 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 2Health News:New Book Features Powerful Stories of People Who Overcame Addiction 3
... international team of researchers led by the University of East ... aid the early detection and diagnosis of inflammatory bowel disease. ... microscope which allows clinicians to view the bacteria that are ... disease and ulcerative colitis. "Bacteria within the wall of ...
... Dec. 4 (HealthDay News) -- Advances in the treatment ... according to two studies scheduled to be presented at ... Fla. Results from one study suggest that treating ... while another group of researchers are scheduled to report ...
... Medical Intensive Care Unit (MICU) at Vanderbilt University Medical Center for ... H1N1 flu pandemic. The tall and burly Warren County, TN, ambulance ... down and hugged some of the nurses he recognized. ... it for the next 20 days. I am just so grateful ...
... , FRIDAY, Dec. 3 (HealthDay News) -- ... cancer fell after doctors starting receiving lower Medicare payments ... patients with metastatic prostate cancer stayed steady, a new ... in the Journal of the National Cancer Institute ...
... News) -- Education and rule enforcement reduce brain and ... equipment such as headgear and mouthguards does not lower ... came to that conclusion after analyzing previous studies of ... rugby players, including six that examined the use of ...
... HealthDay Reporter , FRIDAY, Dec. 3 (HealthDay News) -- While good-looking ... may be at a disadvantage, a new study from Israel suggests. ... as likely to generate requests for an interview, the study found. ... percent less likely to get a response, whether or not the ...
Cached Medicine News:Health News:Blood Cancer Advances May Improve Survival 2Health News:Blood Cancer Advances May Improve Survival 3Health News:Over-reactive immune system kills young adults during pandemic flu 2Health News:Over-reactive immune system kills young adults during pandemic flu 3Health News:Over-reactive immune system kills young adults during pandemic flu 4Health News:Medicare Cuts May Have Spurred Drop in Prostate Cancer Treatment 2Health News:Good Looks May Help Land the Interview -- for Men 2Health News:Good Looks May Help Land the Interview -- for Men 3
(Date:4/25/2015)... April 2015 Hospira, Inc. ... Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen ... (EGA) in London über ... Verfügbarkeit von Biosimilars für Patienten. Das ... Papers mit dem Titel „Why extrapolation is ...
(Date:4/24/2015)... 2015  Perrigo Company plc ("Perrigo" or the "Company") ... unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL ... Perrigo for $60.00 per share in cash and 2.2 ... "Offer").  The Board previously concluded that ... the Company and its future growth prospects and was ...
(Date:4/24/2015)... HILL, N.C. , April 24, 2015 /PRNewswire/ ... the ability of consumers to educate themselves about ... expanded the tools and techniques available to market ... Given the changing consumer marketplace, it,s imperative that ... approaches to better identify market opportunities, niches and ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... and WALTHAM, Mass., May 25, 2011 Interleukin Genetics, Inc. ... USP Hospitales now offers the innovative Heart Health Genetic ... Hospitales, the flagship hospital in Madrid, and will soon ... identifies single nucleotide variations in two Interleukin-1 (IL-1) genes ...
... retains Adapt IP Ventures to market XDATA,s intellectual ... breast cancer detection. Over many decades, XDATA has ... automatically capturing and combining ultrasound and X-ray mammography ... patents, leading companies and research hospitals including GE, ...
Cached Medicine Technology:USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 2USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 3USP Hospitales of Spain to Offer Interleukin Genetics' Heart Health Test Throughout Its Hospital Network 4XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System 2
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: